The company’s earnings beat Wall Street’s profit expectations but revenue missed forecasts.
Big jumps in sales of prescription drugs & medical devices helped Johnson & Johnson boost its first-quarter profit by nearly 7%.
mRNA COVID-19 vaccines are sailing along as viral vector shots encounter setback after setback. How will it affect vaccine sales in 2021?
The US government has ordered 100 million doses and J&J says it can meet this commitment by June.